The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLC's (a subsidiary of Pfizer) Celebrex capsules of strength of 50 mg, 100 mg, 200 mg and 400 mg, the ...

PITTSBURGH, Dec. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic ...

Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

Zydus Lifesciences Limited, a pharma firm has received final approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, the ...

Lupin’s Celecoxib capsules are the AB-rated generic equivalents of GD Searle LLC ‘s Celebrex capsules Lupin has received final approval for its Celecoxib capsules, 50 mg from the US Food and Drugs ...

Strides Pharma has said that its step-down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg, and 400 mg, from the United ...

Mumbai, Baltimore, December 11, 2014: Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D.

Shares of Unichem Laboratories were trading at ₹280.55 per scrip on BSE, up 1.04% from its previous close. Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health ...

Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic Celecoxib capsules used for treatment of osteoarthritis, rheumatoid ...